Setup News Ticker
Searching for 'Today Stock'. (Return)

KiplingerJul 13, 2020
Stock Market Today: This Is Your Market on (Coronavirus) Drugs
News about coronavirus drugs in development gave the market an early spark on Monday, but this time it wasn't Gilead Sciences' (GILD) remdesivir - it was Pfizer (PFE, 4.1%) and smaller BioNTech (BNTX, 10.6%). The FDA granted the two companies a Fast Track designation for a pair of COVID-19 vaccine candidates that are currently in early-phase clinical studies.

PepsiCo (PEP, 0.3%) also delivered some good news in the form of a second-quarter profit beat ahead of meatier reports on this week's earnings calendar.

25 Stocks That Billionaires Are Selling But a rip-roaring morning turned volatile as the day went on, and the rally eventually unraveled in spectacular fashion as California moved to close indoor operations of restaurants, bars and movie theaters across the state, as well as other businesses in 30 counties. Tesla (TSLA), for instance, gained as much as 16% before swinging to a 3.1% loss.

The Dow ultimately dropped 553 points from its peak to finish just 10 points higher to 26,085. The S&P 500 declined 0.9% to 3,155, and the Russell 2000 fell 1.3% to 1,403. Tech stocks lost some steam, sending

The Motley FoolJul 13, 2020
Why Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Sank Today
California's decision to reverse its reopening plans is an ominous sign for the beleaguered cruise industry.

Nikola Corporation, Blink Charging, and Electrameccanica Vehicles Stocks All Dropped Today (The Motley Fool)
Why Alternative Fuel Stocks Plunged by Double Digits Today (The Motley Fool)

Yahoo BusinessJul 13, 2020
Why Vaxart's Stock Is Trading Higher Today
Vaxart Inc (NASDAQ: VXRT) shares are trading higher on Monday after B Riley FBR initiated coverage on the company's stock with a Buy rating and announced a $22 price target.The company also raised about $90 million in gross proceeds through at-the-market-facility.Vaxart is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally.The company has three product candidates which are; Influenza, Norovirus and RSV Vaccine, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. Geographically all the business activity is functioned through the region of the US.Vaxart shares were trading up 50.25% at $11.99 at the time of publication on Monday. The stock has a 52-week high of $14.30 and a 52-week low of 25 cents.Latest Ratings for VXRT DateFirmActionFromTo Jul 2020B. Riley FBRInitiates Coverage OnBuy Apr 2020HC Wainwright & Co.ReiteratesBuy Jun 2019H.C. WainwrightInitiates Coverage OnBuy View More Analyst Ratings for VXRT View the Latest Analyst RatingsSee more from Benzinga * 4 Cybersecurity Investment Opportunities Tied To The Rise In Online Threats * With E-Commerce Shift Underway, BofA Has High Expectations For PayPal's Q2 * Why Herbalife's Stock Is Trading Higher Today(C) 2020 Benzinga does not provide investment advice. All rights reserved.

USA Today MoneyJul 13, 2020
Stocks give up gains in roller-coaster trading
U.S. stocks swung to losses in the final hour of trading Monday, after investors weighed another surge in coronavirus cases with signs of progress for a vaccine.      
StockMarket rise Tesla Today earnings
Coronaviruscases rise WHO latest vaccine
StocksRise Earnings These Markets Pfizer
MarketStock earnings Stocks rise Monday
Chinasanctions lawmakers claims South Sea
COVID-19Company vaccine Pfizer BioNTech York
BroncoFord Reveal off-road Jeep Years
Risecoronavirus futures earnings cases shares
TeslaStock Model Y biggest Musk
Sharesrise European turns EU recovery

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News Analysis Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News - China, Economy & Trade - Financial Markets - Hedge Funds - Telecoms - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC